Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Akers Biosciences (AKER)

Akers Biosciences (AKER)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,668
  • Shares Outstanding, K 8,860
  • Annual Sales, $ 1,580 K
  • Annual Income, $ -3,890 K
  • 60-Month Beta 0.33
  • Price/Sales 7.62
  • Price/Cash Flow N/A
  • Price/Book 1.38
Trade AKER with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.73 +6.59%
on 02/23/21
5.24 -44.47%
on 02/16/21
+0.21 (+7.78%)
since 02/03/21
3-Month
1.93 +50.39%
on 12/30/20
5.24 -44.47%
on 02/16/21
+0.89 (+44.06%)
since 12/03/20
52-Week
1.55 +87.74%
on 03/16/20
8.85 -67.12%
on 04/07/20
+0.11 (+3.93%)
since 03/03/20

Most Recent Stories

More News
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

PAND : 61.63 (+0.65%)
PRAH : 144.77 (+1.38%)
AEGN : 25.72 (-0.31%)
PTVCA : 22.95 (-0.22%)
CRHM : 3.86 (unch)
CBLI : 5.94 (-1.82%)
AKER : 2.91 (-3.32%)
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / , founder and managing partner at , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered...

CBLI : 5.94 (-1.82%)
AKER : 2.91 (-3.32%)
SPWH : 16.97 (-0.03%)
MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. ("MyMD"), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing...

AKER : 2.91 (-3.32%)
Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. ("MyMD"), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing...

AKER : 2.91 (-3.32%)
Akers Biosciences Responds to Erroneous Earnings Call Press Release

Akers Biosciences, Inc. (the "Company") (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company....

AKAAF : 87.0000 (+91.21%)
AKER : 2.91 (-3.32%)
Aker ASA to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 17, 2021 / Aker ASA (NASDAQ:AKER) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 17, 2021 at 9:00 AM Eastern...

AKAAF : 87.0000 (+91.21%)
AKER : 2.91 (-3.32%)
Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - RNET, PRGX, EGOV, AKER, WDR, HMSY

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

RNET : 9.48 (-0.84%)
PRGX : 7.71 (+0.13%)
EGOV : 34.46 (+0.03%)
AKER : 2.91 (-3.32%)
WDR : 25.09 (-0.04%)
HMSY : 36.82 (+0.03%)
AKERS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AKER and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Akers Biosciences, Inc. (NASDAQ: AKER) breached their fiduciary...

AKER : 2.91 (-3.32%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - XLNX, IPHI, NAV, AKER, INFO

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

XLNX : 123.51 (-4.96%)
IPHI : 158.93 (-3.17%)
NAV : 44.16 (-0.20%)
AKER : 2.91 (-3.32%)
INFO : 89.49 (-2.44%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLIX, XLNX, SNSS, and AKER Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

HLIX : 0.8400 (+9.09%)
XLNX : 123.51 (-4.96%)
SNSS : 5.32 (+24.30%)
AKER : 2.91 (-3.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in...

See More

Key Turning Points

3rd Resistance Point 3.24
2nd Resistance Point 3.17
1st Resistance Point 3.04
Last Price 2.91
1st Support Level 2.84
2nd Support Level 2.77
3rd Support Level 2.64

See More

52-Week High 8.85
Fibonacci 61.8% 6.06
Fibonacci 50% 5.20
Fibonacci 38.2% 4.34
Last Price 2.91
52-Week Low 1.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar